array biopharma inc (ARRY:NASDAQ GM)
Neil L. Spector M.D.
Member of Scientific Advisory Board, Array BioPharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Neil L. Spector, M.D. serves as Director of Translational Research in Oncology, Cancer Drug Development Team of Duke University Medical Center. Dr. Spector also serves as Co-Director of the Experimental Therapeutics Program in the cancer center. He has 20 years of oncology experience. Dr. Spector served as Clinical Advisor of Syndax Pharmaceuticals, Inc. Prior to joining Duke, Dr. Spector served as Director of GlaxoSmithKline's Exploratory Medical Sciences in Oncology, ...
3200 Walnut StreetPhone: 303-381-6600
Boulder, Colorado 80301
Board Members Memberships*There is no Board Members Memberships data available.
New Jersey Medical School, University of Medicine and Dentistry of New Jersey
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Harvey J. Berger M.D.||Principal Founder, Chairman of the Board, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Daniel R. Passeri MSc., J.D.||Chief Executive Officer and Director|
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Werner Lanthaler MBA/MPA||Chief Executive Officer|
|Adelene Q. Perkins||Chairman of The Board, Chief Executive Officer and President|
Infinity Pharmaceuticals, Inc.
|$536.0K||Compensation as of Fiscal Year 2012.|